在NOD2驱动的克罗恩病中,骨髓层和gp130救援
Shikha Nayar1,2, Joshua K Morrison3, Mamta Giri4
1Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
克罗恩病中NOD2的损失会破坏细胞平衡,导致纤维化. 阻断gp130在治疗这种炎症性肠病方面是有前途的,并可能增强抗TNF治疗反应.
科学领域:
- 胃肠病学
- 免疫学
- 分子生物学
背景情况:
- 克罗恩病包括慢性肠道炎症,异常愈合,
- 在克罗恩病的发病过程中,
- NOD2突变是与严格排尿并发症相关的高风险基因.
研究的目的:
- 在克罗恩病中研究NOD2突变致病机制.
- 确定可能克服抗TNF治疗不响应的途径.
- 探索针对骨髓细胞相互作用的治疗策略.
主要方法:
- 对具有NOD2风险等位基因的患者进行直接的体外分析.
- CD14+外周血液单核细胞的表征
- 使用nod2缺陷斑马鱼模型进行肠道损伤研究.
- 在体内评估使用bazedoxifene抑制gp130.
主要成果:
- 由于NOD2缺乏,激活的纤维细胞和巨细胞的稳态失调.
- 携带NOD2风险等位基因的细胞表现出高原产量.
- STAT3通路的激活与对抗TNF治疗的不响应相关.
- 斑马鱼的gp130阻塞改善了激活的骨髓.
结论:
- 在克罗恩病中,NOD2突变通过骨髓层细胞失调驱动纤维化.
- STAT3通路的激活是抗TNF治疗失败的标志物.
- 可能与巴兹多克西芬结合的gp130阻塞可能为克罗恩病提供一种新的治疗方法,可能是补充抗TNF疗法.
更多相关视频
11:06Combining Intravital Fluorescent Microscopy IVFM with Genetic Models to Study Engraftment Dynamics of Hematopoietic Cells to Bone Marrow Niches
Published on: March 21, 2017
08:37Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Stem Cell Niche
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Multipotency and Niche of Bulge Stem Cell
